litlas
ログインアカウント作成

Nicholas J. Robert

1984–2024 年に発表

61
論文数
18,793
被引用数
51
h 指数
59
i10 指数

被引用数

Nicholas J. Robert の年別被引用数1971 年: 被引用 1 件1974 年: 被引用 1 件1984 年: 被引用 1 件1986 年: 被引用 1 件1987 年: 被引用 4 件1988 年: 被引用 2 件1989 年: 被引用 2 件1990 年: 被引用 2 件1991 年: 被引用 5 件1992 年: 被引用 3 件1993 年: 被引用 6 件1994 年: 被引用 13 件1995 年: 被引用 18 件1996 年: 被引用 14 件1997 年: 被引用 29 件1998 年: 被引用 24 件1999 年: 被引用 29 件2000 年: 被引用 42 件2001 年: 被引用 74 件2002 年: 被引用 89 件2003 年: 被引用 91 件2004 年: 被引用 89 件2005 年: 被引用 102 件2006 年: 被引用 99 件2007 年: 被引用 144 件2008 年: 被引用 145 件2009 年: 被引用 130 件2010 年: 被引用 144 件2011 年: 被引用 133 件2012 年: 被引用 145 件2013 年: 被引用 137 件2014 年: 被引用 116 件2015 年: 被引用 119 件2016 年: 被引用 118 件2017 年: 被引用 123 件2018 年: 被引用 116 件2019 年: 被引用 388 件2020 年: 被引用 373 件2021 年: 被引用 353 件2022 年: 被引用 297 件2023 年: 被引用 214 件2024 年: 被引用 326 件2025 年: 被引用 137 件1972〜1973 年は被引用が無いため表示していません1975〜1983 年は被引用が無いため表示していません1985 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,915 件、この内訳の 28.7%イギリス: 引用元論文 441 件、この内訳の 6.6%イタリア: 引用元論文 386 件、この内訳の 5.8%中国: 引用元論文 381 件、この内訳の 5.7%ドイツ: 引用元論文 320 件、この内訳の 4.8%カナダ: 引用元論文 304 件、この内訳の 4.6%スペイン: 引用元論文 260 件、この内訳の 3.9%フランス: 引用元論文 243 件、この内訳の 3.6%スイス: 引用元論文 212 件、この内訳の 3.2%ベルギー: 引用元論文 190 件、この内訳の 2.8%オーストラリア: 引用元論文 180 件、この内訳の 2.7%日本: 引用元論文 152 件、この内訳の 2.3%
0%28.7%その他 25.3%

機関

分野

  • Medicine62.1%
  • Biochemistry, Genetics and Molecular Biology30.1%
  • Immunology and Microbiology1.8%
  • Materials Science1.3%
  • Computer Science0.8%
  • Nursing0.7%
  • その他3.2%

トピック

  • HER2/EGFR in Cancer Research12.1%
  • Breast Cancer Treatment Studies9.9%
  • Cancer Treatment and Pharmacology5.3%
  • Advanced Breast Cancer Therapies4.8%
  • Monoclonal and Polyclonal Antibodies Research4.7%
  • Estrogen and related hormone effects2.7%
  • その他60.5%

共著者

全論文

検索で開く
  1. Adjuvant Trastuzumab in HER2-Positive Breast Cancer

    著者: Dennis J. Slamon, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, Miguel Martín, Michael F. Press, John R. Mackey, John A. Glaspy, Arlene Chan, Marek Pawlicki, Tamás Pintér, Vicente Valero, Mei-Ching Liu, Guido Sauter, Gϋnter von Minckwitz, F. Visco, Valerie Bée, Marc Buyse, Belguendouz Bendahmane, Isabelle Tabah-Fisch, Mary-Ann Lindsay, A. Riva, John Crown - New England Journal of Medicine 2011 被引用: 2,775

  2. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

    著者: Jeremy Braybrooke, Rosie Bradley, Richard Gray, Robert K. Hills, Hongchao Pan, Richárd Pető, David Dodwell, Paul McGale, Carolyn Taylor, Tomohiko Aihara, Stewart Anderson, Joanne L. Blum, Fátima Cardoso, Xiaosong Chen, John Crown, Bent Ejlertsen, Thomas W. P. Friedl, Nadia Harbeck, Wolfgang Janni, Maj‐Britt Jensen, E. Mamounas, Kazutaka Narui, Ulrike Nitz, Larry Norton, Joyce O’Shaughnessy, Martine Piccart, Nicholas J. Robert, Zhi‐Ming Shao, Dennis Slamon, Joseph A. Sparano, Toru Watanabe, Greg Yothers, Ke‐Da Yu, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Lui, Zulian Lui, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Aman U. Buzdar, Vera J. Suman, Kelly K. Hunt, Robert Leonard, Janine Mansi, Catherine Delbaldo, Pascal Piedbois, Emmanuel Quinaux, Christian Fesl, Michael Gnant, Lidija Sölkner, Guenther G. Steger, Hans Petter Eikesdal, Per Eystein Lønning, Valerie Bée, Helena Fung, John R. Mackey, Miguel Martín, Michael F. Press, Evandro de Azambuja, Richard D. Gelber, Meredith M. Regan, Angelo Di Leo, Veerle Van Dooren, J.-M. Nogaret, John M.S. Bartlett, Bingshu E. Chen, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Kathleen I. Pritchard, Lois E. Shepherd, Donald A. Berry, Constance Cirrincione, Lawrence N. Shulman, Eric P. Winer, Rebecca Gelman, Jay R. Harris, Craig Henderson, Charles L. Shapiro, Peer Christiansen, Marianne Ewertz, Henning T. Mouridsen, Elise Van Leeuwen, Sabine C. Linn, Annelot G.J. van Rossum, Harm van Tinteren ほか 136 名 - The Lancet 2023 被引用: 189

  3. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Miguel Martín, Frankie A. Holmes, Bent Ejlertsen, Suzette Delaloge, Beverly Moy, Hiroji Iwata, Gϋnter von Minckwitz, Stephen Chia, Janine Mansi, Carlos H. Barrios, Michael Gnant, Z. Tomasevic, Neelima Denduluri, Robert Šeparović, Erhan Gökmen, Anna Bashford, Manuel Ruíz Borrego, Sung‐Bae Kim, Erik Jakobsen, A. Ciceniene, Kenichi Inoue, Friedrich Overkamp, Joan B. Heijns, Anne Armstrong, John S. Link, Anil A. Joy, Richard Bryce, Alvin Wong, Susan Moran, Bin Yao, Feng Xu, Alan Auerbach, Marc Buyse, Arlene Chan, Vernon Harvey, Rudolf Tomek, Nicholas J. Robert, Ira Gore, John W. Smith, Norikazu Masuda, S. Di Sean Kendall, William Graydon Harker, Katarína Petráková, Ángel Guerrero‐Zotano, Amparo Ruiz Simón, Zora Neskovic Konstantinovic, Nicholas Iannotti, Pierfrancesco Tassone, Gladys Rodriguez, Noelia Jáñez Martínez, Carmen Crespo Massieu, Snezana Smickoska, Işıl Somali, Uğur Yılmaz, Mirta Garcia Alonso, Adolfo Rosales, Soeren Cold, Ann Knoop, Debra A. Patt, Beth A. Hellerstedt, Serafin Morales Murillo, Ingrid A. Mayer, Julie A. Means‐Powell, Rina Hui, Francis M. Senecal, Richard Hendry De Boer, Zhenzhou Shen, A.A. Luczak, Joanna W.Y. Chui, Janice Tsang, István Láng, Yoshiaki Rai, Yasuo Hozumi, Albert J. ten Tije, Manish Bhandari, Cynthia R. Osborne, Shoichiro Ohtani, Kenji Higaki, Kenichi Watanabe, Kazunori TAGUCHI, Masato Takahashi, Sladjana Filipovic, Vincent Hansen, Vijayarama Phooshkooru Rao, Manish Gupta, Petar Petrov, Bruno Coudert, Željko Vojnović, Zsofia Polya, Toshiko Miyaki, Naohito Yamamoto, Stephen Brincat, Krzysztof Leśniewski-Kmak, Ewa Chmielowska, Ruemu Birhiray, Marc L. Citron, Steven W. Papish, William L. Berry, Sven Tyge Langkjer, José Á. García-Sáenz ほか 526 名 - The Lancet Oncology 2017 被引用: 589

  4. Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

    著者: Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, Nicholas J. Robert, Hyman B. Muss, Julie R. Gralow, Karen A. Gelmon, Timothy J. Whelan, Kathrin Strasser‐Weippl, S. Rubin, Keren Sturtz, Antonio C. Wolff, Eric P. Winer, Clifford A. Hudis, Alison Stopeck, J. Thaddeus Beck, Judith S. Kaur, Kate Whelan, Dongsheng Tu, Wendy R. Parulekar - New England Journal of Medicine 2016 被引用: 648

  5. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Arlene Chan, Suzette Delaloge, Frankie A. Holmes, Beverly Moy, Hiroji Iwata, Vernon Harvey, Nicholas J. Robert, Tajana Silovski, Erhan Gökmen, Gϋnter von Minckwitz, Bent Ejlertsen, Stephen Chia, Janine Mansi, Carlos H. Barrios, Michael Gnant, Marc Buyse, Ira Gore, John W. Smith, Graydon Harker, Norikazu Masuda, Katarína Petráková, Ángel Guerrero Zotano, Nicholas Iannotti, Gladys Rodriguez, Pierfrancesco Tassone, Alvin Wong, Richard Bryce, Yining Ye, Bin Yao, Miguel Martín - The Lancet Oncology 2016 被引用: 565

  6. RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer

    著者: Nicholas J. Robert, Véronique Dièras, John A. Glaspy, Adam Brufsky, Igor Bondarenko, Oleg Lipatov, Edith A. Perez, Denise A. Yardley, Stephen Chan, Xian Zhou, S. Phan, Joyce O’Shaughnessy - Journal of Clinical Oncology 2011 被引用: 1,061

  7. Biomarker testing and tissue journey among patients with metastatic non-small cell lung cancer receiving first-line therapy in The US Oncology Network

    著者: Nicholas J. Robert, Janet L. Espirito, Liwei Chen, Esmond Nwokeji, Mandar Karhade, Makenzi Colleen Evangelist, Alexander I. Spira, Marcus A. Neubauer, Susie Bullock, Jennifer Walberg, Steven K. Cheng, Robert L. Coleman - Lung Cancer 2022 被引用: 80

  8. Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

    著者: Melody Cobleigh, Charles L. Vogel, Debu Tripathy, Nicholas J. Robert, Suzy Scholl, Louis Fehrenbacher, Janet Wolter, Virginia Paton, Steven Shak, Gracie Lieberman, Dennis J. Slamon - Journal of Clinical Oncology 1999 被引用: 2,790

  9. Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)

    著者: Joanne L. Blum, Patrick J. Flynn, Greg Yothers, Lina Asmar, Charles E. Geyer, Samuel A. Jacobs, Nicholas J. Robert, Judith O. Hopkins, Joyce O’Shaughnessy, Chau T. Dang, Henry Gómez, Louis Fehrenbacher, Svetislava J. Vukelja, Alan P. Lyss, Devchand Paul, Adam Brufsky, Jong‐Hyeon Jeong, Linda H. Colangelo, Sandra M. Swain, Eleftherios P. Mamounas, Stephen E. Jones, Norman Wolmark - Journal of Clinical Oncology 2017 被引用: 288

  10. Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era

    著者: Neil J. Shah, Sneha Sura, Reshma Shinde, Junxin Shi, Puneet K. Singhal, Nicholas J. Robert, Nicholas J. Vogelzang, Rodolfo F. Perini, Robert J. Motzer - European Urology Open Science 2023 被引用: 58

  11. The Friends of Cancer Research Real‐World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies

    著者: Donna R. Rivera, Henry J. Henk, Elizabeth Garrett‐Mayer, Jennifer Christian, Andrew J. Belli, Suanna S. Bruinooge, Janet L. Espirito, Connor Sweetnam, Monika A. Izano, Yanina Natanzon, Nicholas J. Robert, Mark S. Walker, Aaron B. Cohen, Marley Boyd, Lindsey Enewold, Eric Hansen, Rebecca Honnold, Lawrence H. Kushi, P Kalyani, Ruth Pe Benito, Lori C. Sakoda, Elad Sharon, Olga Tymejczyk, Emily Valice, Joseph Wagner, Laura Lasiter, Jeff Allen - Clinical Pharmacology & Therapeutics 2021 被引用: 56

  12. Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

    著者: Paul E. Goss, James N. Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine Piccart, Monica Castiglione, Dongsheng Tu, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David Cameron, Michael Palmer, Joseph L. Pater - JNCI Journal of the National Cancer Institute 2005 被引用: 1,120

  13. Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast Cancer

    著者: Mariaelena Pierobon, Corinne Ramos, Shukmei Wong, K. Alex Hodge, Jessica Aldrich, Sara A. Byron, Stephen P. Anthony, Nicholas J. Robert, Donald W. Northfelt, Mohammad Jahanzeb, Linda Vocila, Julia Wulfkuhle, Guido Gambara, Rosa I. Gallagher, Bryant Dunetz, Nicholas N Hoke, Ting Dong, David W. Craig, Massimo Cristofanilli, Brian Leyland‐Jones, Lance A. Liotta, Joyce O’Shaughnessy, John D. Carpten, Emanuel F. Petricoin - Clinical Cancer Research 2017 被引用: 96

  14. Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapy

    著者: C. Lance Cowey, Nicholas J. Robert, Janet L. Espirito, Kalatu Davies, Jennifer R. Frytak, Israel Lowy, Matthew G. Fury - Cancer Medicine 2020 被引用: 54

  15. Understanding Contemporary Molecular Biomarker Testing Rates and Trends for Metastatic NSCLC Among Community Oncologists

    著者: David Waterhouse, Wan-Yu Tseng, Janet L. Espirito, Nicholas J. Robert - Clinical Lung Cancer 2021 被引用: 29

  16. Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer

    著者: Joyce O’Shaughnessy, Lee Schwartzberg, Michael A. Danso, Kathy D. Miller, Hope S. Rugo, Marcus A. Neubauer, Nicholas J. Robert, Beth A. Hellerstedt, Mansoor N. Saleh, Paul Richards, Jennifer M. Specht, Denise A. Yardley, Robert W. Carlson, Richard S. Finn, Éric Charpentier, Ignacio Garcia‐Ribas, Eric P. Winer - Journal of Clinical Oncology 2014 被引用: 305

  17. Comparisons of Real-World Time-to-Event End Points in Oncology Research

    著者: Brigham Walker, Marley Boyd, Kat Aguilar, Kalatu Davies, Janet L. Espirito, Jennifer R. Frytak, Nicholas J. Robert - JCO Clinical Cancer Informatics 2021 被引用: 64

  18. Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer

    著者: Valentina Guarneri, David Miles, Nicholas J. Robert, Véronique Dièras, John A. Glaspy, Ian Smith, Christoph Thomssen, Laura Biganzoli, Tanya Taran, PierFranco Conte - Breast Cancer Research and Treatment 2010 被引用: 285

  19. Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy

    著者: Michael F. Press, Guido Sauter, Marc Buyse, Leslie Bernstein, Roberta Guzman, Angela Santiago, Ivonne Villalobos, W. Eiermann, Tadeusz Pieńkowski, Miguel Martín, Nicholas J. Robert, John Crown, Valerie Bée, Henry Taupin, Kerry Flom, Isabelle Tabah-Fisch, Giovanni M. Pauletti, Mark A. Lindsay, A. Riva, Dennis J. Slamon - Journal of Clinical Oncology 2010 被引用: 220

  20. Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor–Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group

    著者: Amyé Tevaarwerk, Μolin Wang, Fengmin Zhao, John H. Fetting, David Cella, Lynne I. Wagner, Silvana Martino, James N. Ingle, Joseph A. Sparano, Lawrence J. Solin, William C. Wood, Nicholas J. Robert - Journal of Clinical Oncology 2014 被引用: 148

  21. Analysis of Fcγ Receptor IIIa and IIa Polymorphisms: Lack of Correlation with Outcome in Trastuzumab-Treated Breast Cancer Patients

    著者: Sara A. Hurvitz, David J. Betting, Howard M. Stern, Emmanuel Quinaux, Jeremy Stinson, Somasekar Seshagiri, Ying Zhao, Marc Buyse, John R. Mackey, Adrian Driga, Sambasivarao Damaraju, Mark X. Sliwkowski, Nicholas J. Robert, Vicente Valero, John Crown, Carla I. Falkson, Adam Brufsky, Tadeusz Pieńkowski, W. Eiermann, Miguel Martín, Valerie Bée, Omkar Marathe, Dennis J. Slamon, John M. Timmerman - Clinical Cancer Research 2012 被引用: 111

  22. Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology])

    著者: Charles E. Geyer, Joanne L. Blum, Greg Yothers, Lina Asmar, Patrick J. Flynn, Nicholas J. Robert, Judith O. Hopkins, Joyce O’Shaughnessy, Priya Rastogi, Shannon L. Puhalla, Christie Hilton, Chau T. Dang, Henry L. Gómez, Svetislava J. Vukelja, Alan P. Lyss, Devchand Paul, Adam Brufsky, Linda H. Colangelo, Sandra M. Swain, Eleftherios P. Mamounas, Norman Wolmark - Journal of Clinical Oncology 2024 被引用: 22

  23. Phase II Study of Weekly Albumin-Bound Paclitaxel for Patients with Metastatic Breast Cancer Heavily Pretreated with Taxanes

    著者: Joanne L. Blum, Michael A. Savin, Gerald M. Edelman, John Pippen, Nicholas J. Robert, Brian V. Geister, Robert Kirby, Alicia Clawson, Joyce O’Shaughnessy - Clinical Breast Cancer 2007 被引用: 178

  24. Real‐world outcomes of 18,186 metastatic solid tumor outpatients: Baseline blood cell counts correlate with survival after immune checkpoint inhibitor therapy

    著者: Jerome H. Goldschmidt, Lin‐Na Chou, Philip K. Chan, Liwei Chen, Nicholas J. Robert, Joyce Kinsey, Katherine Pitts, Matt Nestor, Edwin P. Rock, Hillard M. Lazarus - Cancer Medicine 2023 被引用: 26